Claims for Patent: 6,458,581

Summary for Patent: 6,458,581

Title:	Process for the in vitro culture of different stages of tissue parasites
Abstract:	The present invention provides a method for carrying out in vitro the complete developmental sequence culture of tissular parasites, which includes culturing the parasites in a totally defined culture medium which is an axenic monophasic liquid culture medium, free of serum and free of serum-derived or cell-derived macromolecules, proteins and peptides. For obtaining amastigote forms, this medium is buffered at a pH of 5.5 to 6.5 and has an osmolarity of at least 400 milliosmoles/kg of liquid. For obtaining promastigote forms, the medium is buffered at a pH of 7 to 7.5 and has an osmolarity of at least 300 milliosmoles/kg liquid. Application to the in vitro culture of different stages of tissular parasites such as Leishmania, T. cruzi, and hamatoprotozoa is also provided.
Inventor(s):	Lemesre; Jean-Loup (Saint Martin de Londres, FR)
Assignee:	Institut francais de recherche scientifique pour le developpement en (N/A) (Paris, FR)
Application Number:	08/549,677
Patent Claims:	1. A method for the in vitro culture of different stages of tissue parasites, consisting of culturing said parasites in a totally defined culture medium, which is an axenic, monophasic liquid culture medium, which is devoid of serum, and for obtaining amastigote forms, is buffered at a pH of 5.5 to 6.5 and has an osmolarity of at least 400 milliosmoles/kg of liquid, or, for obtaining promastigote forms, is buffered at a pH of 7 to 7.5 and has an osmolarity of at least 300 milliosmoles/kg of liquid, wherein said culture medium contains a basic culture medium for insect cells and at least one of an inorganic salt, a source of amino acids, and a sugar. 2. The method of claim 1, wherein the culture medium for insect cells is 199H M medium and the inorganic salts are Hanks' salts. 3. The method of claim 1, wherein the products which are sources of amino acids are selected from the group consisting of L-glutamine and soja bean extracts. 4. The method of claim 1, wherein the sugars are D-glucose. 5. The method of claim 1, comprising the steps of adding to the base medium, at the time of use, an anti-oxidizing agent, an agent with a reducing effect and vitamins. 6. The method of claim 5, wherein, for the culture of amastigote forms, said culture medium contains a base medium consisting essentially of 8 to 15% (v/v) of said cellular culture medium, 4 to 8% (w/v) of amino acids, 2 to 4% (w/v) of sugars, 0.0002 to 0.0015 (w/v) of anti-oxidizing agent, 0.05% (w/v) of reducing agent, and 1 to 5% (v/v) of vitamins. 7. The method of claim 6, wherein, for the culture of amastigote forms, said culture medium contains a base medium consisting essentially of 10% (v/v) of said cellular culture medium, 5 to 6% (w/v) of amino acids, 2 to 3% (w/v) of sugars, 0.0005% (w/v) of anti-oxidizing agent, 0.025% (w/v) of reducing agent, and 2% (v/v) of vitamins. 8. The method of claim 1, wherein the culture medium for insect cells further comprises at least one compound selected from the group consisting of a sulphurous compound, an anti-oxidizing agent, a reducing agent, and a vitamin. 9. The method of claim 8, wherein said at least one compound is selected from the group consisting of a sulphurous compound which is present in an amount of 0.25 to 0.50% (w/v) and bathocuproine sulphonic acid which is present in an amount of 0.004 to 0.008% (v/v). 10. The method of claim 9, wherein said sulphurous compound and bathocuproine sulphonic acid are present in an amount of 0.3% (w/v) and 0.005% (v/v) respectively. 11. The method of claim 8, wherein said sulphurous compound is cysteine. 12. The method of claim 1, wherein culturing of promastigote stages is carried out in a culture medium comprising RPMI 1640 medium, amino-acids and a buffer to adjust the pH to a value of 7 to 7.5, and 199H M medium containing inorganic salts and anti-oxidizing agents. 13. The method of claim 12, wherein the inorganic salts are Hank's salts and the anti-oxidizing agent is hemin. 14. The method of claim 12, comprising using at least 2% (v/v) of 199H M medium and 0.0002 to 0.0015% (w/v) of anti-oxidizing agent. 15. The method of claim 14, comprising using 2 to 10% (v/v) of 199H M medium, and 0.0005% of anti-oxidizing agent. 16. The method of claim 1, wherein the tissue parasites, are selected from the group consisting of Leishmania. T. cruzi and hemoprotozoa. 17. A method for the in vitro culture of different stages of tissue parasites, consisting of culturing said parasites in a totally defined culture medium, which is an axenic, monophasic liquid culture medium, which is devoid of serum macromolecules which are non-dialyzable at a cut-off threshold of 3 kDa, and for obtaining amastigote forms, is buffered at a pH of 5.5 to 6.5 and has an osmolarity of at least 400 milliosmoles/kg of liquid, or, for obtaining promastigote forms, is buffered at a pH of 7 to 7.5 and has an osmolarity of at least 300 milliosmoles/kg of liquid, wherein said culture medium contains a basic culture medium for insect cells including at least one of an inorganic salt, a source of amino acids, and a sugar.

Details for Patent 6,458,581

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2013-05-13